FDMT · 4D Molecular Therapeutics, Inc.
$9.61
-0.24 (-2.44%)
At close · Jul 29
Market Cap
$681.74M
Shares
69.21M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-30 | SCOTT BIZILY | Officer | 6,566 | 2026-06-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-23 | SCOTT BIZILY | Officer | 9,810 | 2026-06-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-16 | SCOTT BIZILY | Officer | 1,635 | 2025-12-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-17 | SCOTT BIZILY | Officer | 1,635 | 2025-11-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-10-24 | SCOTT BIZILY | Officer | 1,816 | 2025-10-24 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-23 | SCOTT BIZILY | Officer | 7,312 | 2025-09-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-07-01 | SCOTT BIZILY | Officer | 9,498 | 2024-07-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-04-01 | SCOTT BIZILY | Officer | 13,403 | 2024-04-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-02-08 | SCOTT BIZILY | Officer | 17,738 | 2024-02-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-04-21 | Jacob Chacko | Affiliate | 15,000 | 2023-04-21 | JPMorgan Securies LLC |
| 2023-04-21 | Scott Bizily | Officer | 9,747 | 2023-04-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–11 of 11 filings
Key facts
CIK
1650648
CUSIP
35104E100
13F (30d)
22 filings
22 filers
Visit website
Investor relations